[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-148439-es":3,"doc-seo-148439-110":31,"detail-sidebar-cat-0-es-110":92},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":20,"is_deleted":4,"is_public":21,"is_downloadable":21,"audit_status":21,"page_count":22,"language":23,"language_code":24,"site_id":25,"html_lang":24,"table_of_contents":26,"faqs":27,"seo_title":28,"seo_description":14,"update_tm":29,"read_time":30},148439,1099514068035,"Ezra","https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c",40,"Salud y Atención Médica","Documento de consenso sobre el rol de la vacunación en adultos para la prevención de eventos cardiovasculares - Artículo especial - Revisión","Las enfermedades cardiovasculares constituyen la principal causa de muerte en adultos en Argentina y a nivel mundial. La evidencia disponible sostiene una asociación consistente entre infecciones —en particular respiratorias— y mayor riesgo de eventos cardiovasculares, accidente cerebrovascular, arritmias, mortalidad cardiovascular y mortalidad total. Los mecanismos implican inflamación sistémica, activación inmune, disfunción endotelial, estados protrombóticos, estimulación simpática y aumento de la demanda miocárdica de oxígeno, agravados por hipoxemia e interferencia del intercambio gaseoso. Las alteraciones pueden desencadenar eventos nuevos o descompensar cardiopatías previas.","ISSN 1669-9106 MEDICINA (Buenos Aires) 2026: 86: 447-476 Special article - Review  \nCONSENSUS DOCUMENT ON THE ROLE OF ADULT VACCINATION IN THE PREVENTION OF CARDIOVASCULAR EVENTS.  \nJOINT STATEMENT BY THE ARGENTINE FEDERATION OF CARDIOLOGY (FAC), ARGENTINE SOCIETY OF CARDIOLOGY (SAC), AND THE ARGENTINE COUNCIL OF CARDIOLOGY  \nRESIDENTS (CONAREC)  \nSEBASTIÁN GARCIA-ZAMORA1,2, LAURA PULIDO3, MARÍA INÉS SOSA LIPRANDI2, FRANCISCO NACINOVICH4, FACUNDO J. BALSANO5, JUAN JOSÉ HERRERA PAZ2, GASTÓN PROCOPIO2, GUILLERMO CURSACK1, JOSÉ PICCO2, GUSTAVO CEREZO1, LUIS CICCO1, DANIEL STECHER4, CLAUDIO MORÓS1, DANIELA GARCIA BRASCA1, NATALIA COCCO1, LUCIA DANA2, MARISA PACHECO OTERO2, MARIO C. SPENNATO2, GERARDO ZAPATA1, ÁLVARO SOSA LIPRANDI1,2  \n1Federación Argentina de Cardiología (FAC), 2Sociedad Argentina de Cardiología (SAC), 3Asociación Argentina de Medicina Respiratoria (AAMR), 4 Especialista en Infectología, 5Consejo Argentino de Residentes de Cardiología  \n(CONAREC), Buenos Aires, Argentina  \nPostal address: Sebastián García Zamora, Servicio de Cardiología, Sanatorio Delta, Mendoza 1560, 2000 Rosario, Santa Fe, Argentina  \nE-mail: sgarciazamora@fmed. uba.ar  \nReceived: 12-VIII-2025  \nAccepted: 27-X-2025  \nAbstract  \nCardiovascular diseases remain the leading cause of death among adults, both in Argentina and worldwide. Numerous studies have established a consistent association between infections –particularly respiratory infections– and an increased risk of cardiovascular events, stroke, arrhythmias, and both cardiovascular and all-cause mortality. The underlying pathophysiological mechanisms include systemic inflammation, immune activation, endothelial dysfunction, prothrombotic states, sympathetic stimulation, and elevated myocardial oxygen demand. In respiratory infections, these effects are further exacerbated by hypoxemia and impaired gas exchange. Such alterations can trigger de novo cardiovascular events or exacerbate preexisting conditions, such as ischemic heart disease or heart failure.  \nIn this context, robust evidence supports the safety of vaccines against Influenza, Pneumococcus, Respiratory Syncytial Virus, COVID-19, and Herpes Zoster in adults, including those with established cardiovascular disease or risk factors. Moreover, these vaccines have demonstrated efficacy in reducing cardiovascular events by mitigating infection-related complications. Notably, influenza vaccination has proven safe even during the  \nacute phase of myocardial infarction, when administered during hospitalization.  \nDespite this strong evidence base, vaccination rates remain suboptimal among individuals with cardiovascular disease, both in Argentina and across Latin America. This consensus document reviews the current evidence linking infections and cardiovascular events, and highlights vaccines as a safe and cost-effective strategy for primary, secondary, and tertiary prevention. It also provides concrete recommendations to improve vaccine coverage and reduce residual cardiovascular risk in the region.  \nKey words: cardiovascular diseases, vaccination, cardiovascular prevention, infectious disease, public health  \nResumen  \nDocumento de consenso sobre el rol de la vacunaciónen adultos para la prevención de eventos cardiovasculares. Posicionamiento conjunto de la Federación Argentina de Cardiología (FAC), Sociedad Argentina de Cardiología (SAC) y el Consejo Argentino de Residentes de Cardiología (CONAREC)  \nMEDICINA (Buenos Aires) 2026; 86: 447-476 447  \nArtículo especial-Revisión Vaccine for cardiovascular prevention  \nLas enfermedades cardiovasculares son la principal causa de muerte en adultos, tanto en Argentina como a nivel global. Existe una relación consistente entre las infecciones, especialmente las respiratorias, y un aumento en los eventos cardiovasculares, cerebrovasculares, arritmias, la mortalidad cardiovascular y total. Los mecanismos involucrados incluyen inflamaciónsistémica, activación inmunitaria, disfunción endotelial, est","cbCain8ZuTfHHzyJ","https://ap.wps.com/l/cbCain8ZuTfHHzyJ","pdf",1509404,3,1,30,"Spanish","es",110,"# Resumen\n## Evidencia sobre mecanismos e impacto clínico\n## Seguridad y eficacia de vacunas en adultos\n## Cobertura vacunal y recomendaciones para prevención","[{\"question\":\"Qué relación establece el documento entre infecciones y eventos cardiovasculares?\",\"answer\":\"El documento describe una asociación consistente entre infecciones, especialmente respiratorias, y aumento del riesgo de eventos cardiovasculares, ACV, arritmias y mortalidad cardiovascular y total.\"},{\"question\":\"Qué mecanismos fisiopatológicos explican el vínculo infección-evento cardiovascular?\",\"answer\":\"Incluyen inflamación sistémica, activación inmunitaria, disfunción endotelial, estados protrombóticos, estimulación simpática y mayor demanda de oxígeno del miocardio; en infecciones respiratorias se suman hipoxemia y alteración del intercambio gaseoso.\"},{\"question\":\"Qué vacunas se consideran seguras y con efecto preventivo en adultos según el consenso?\",\"answer\":\"Se respaldan vacunas contra influenza, neumococo, VSR, COVID-19 y herpes zóster, con evidencia de seguridad en adultos, incluso con enfermedad cardiovascular o factores de riesgo, y eficacia para reducir eventos cardiovasculares al mitigar complicaciones relacionadas con infecciones.\"}]","Documento de consenso sobre el rol de la vacunación en adultos para la prevención de eventos cardiovasculares - Artículo especial - Revisión | PDF",1787779817,46,{"code":4,"msg":32,"data":33},"ok",{"site_id":25,"language":24,"slug":34,"title":13,"keywords":35,"description":14,"schema_data":36,"social_meta":87,"head_meta":89,"extra_data":91,"updated_unix":29},"consensus-document-on-the-role-of-adult-vaccination-in-preventing-cardiovascular-events-special-article-review","",{"@graph":37,"@context":86},[38,54,69],{"@type":39,"itemListElement":40},"BreadcrumbList",[41,45,49,51],{"item":42,"name":43,"@type":44,"position":21},"https://docshare.wps.com","Home","ListItem",{"item":46,"name":47,"@type":44,"position":48},"https://docshare.wps.com/es/document/","Document",2,{"item":50,"name":12,"@type":44,"position":20},"https://docshare.wps.com/es/document/salud-y-atención-médica/",{"item":52,"name":13,"@type":44,"position":53},"https://docshare.wps.com/es/document/consensus-document-on-the-role-of-adult-vaccination-in-preventing-cardiovascular-events-special-article-review/148439/",4,{"url":52,"name":13,"@type":55,"author":56,"headline":13,"publisher":58,"fileFormat":61,"inLanguage":24,"description":14,"dateModified":62,"datePublished":63,"encodingFormat":61,"isAccessibleForFree":64,"interactionStatistic":65},"DigitalDocument",{"name":9,"@type":57},"Person",{"url":42,"name":59,"@type":60},"DocShare","Organization","application/pdf","2026-09-06","2026-08-26",true,{"@type":66,"interactionType":67,"userInteractionCount":20},"InteractionCounter",{"@type":68},"ViewAction",{"@type":70,"mainEntity":71},"FAQPage",[72,78,82],{"name":73,"@type":74,"acceptedAnswer":75},"Qué relación establece el documento entre infecciones y eventos cardiovasculares?","Question",{"text":76,"@type":77},"El documento describe una asociación consistente entre infecciones, especialmente respiratorias, y aumento del riesgo de eventos cardiovasculares, ACV, arritmias y mortalidad cardiovascular y total.","Answer",{"name":79,"@type":74,"acceptedAnswer":80},"Qué mecanismos fisiopatológicos explican el vínculo infección-evento cardiovascular?",{"text":81,"@type":77},"Incluyen inflamación sistémica, activación inmunitaria, disfunción endotelial, estados protrombóticos, estimulación simpática y mayor demanda de oxígeno del miocardio; en infecciones respiratorias se suman hipoxemia y alteración del intercambio gaseoso.",{"name":83,"@type":74,"acceptedAnswer":84},"Qué vacunas se consideran seguras y con efecto preventivo en adultos según el consenso?",{"text":85,"@type":77},"Se respaldan vacunas contra influenza, neumococo, VSR, COVID-19 y herpes zóster, con evidencia de seguridad en adultos, incluso con enfermedad cardiovascular o factores de riesgo, y eficacia para reducir eventos cardiovasculares al mitigar complicaciones relacionadas con infecciones.","https://schema.org",{"og:url":52,"og:type":88,"og:title":13,"og:site_name":59,"og:description":14},"article",{"robots":90,"canonical":52},"index,follow",{"doc_id":7,"site_id":25},{"code":4,"msg":5,"data":93},[94,99,103,107,111,115,119,123,127,129],{"id":95,"doc_module":4,"doc_module_name":47,"category_name":96,"show_sort_weight":97,"slug":98},39,"Cómic",60,"comic",{"id":100,"doc_module":4,"doc_module_name":47,"category_name":101,"show_sort_weight":97,"slug":102},43,"Estilo de Vida","lifestyle",{"id":104,"doc_module":4,"doc_module_name":47,"category_name":105,"show_sort_weight":97,"slug":106},38,"Examen","exam",{"id":108,"doc_module":4,"doc_module_name":47,"category_name":109,"show_sort_weight":97,"slug":110},44,"General","general",{"id":112,"doc_module":4,"doc_module_name":47,"category_name":113,"show_sort_weight":97,"slug":114},41,"Investigación e Informes","research-report",{"id":116,"doc_module":4,"doc_module_name":47,"category_name":117,"show_sort_weight":97,"slug":118},37,"Literatura","literature",{"id":120,"doc_module":4,"doc_module_name":47,"category_name":121,"show_sort_weight":97,"slug":122},22,"Relatos y Novelas","story-novel",{"id":124,"doc_module":4,"doc_module_name":47,"category_name":125,"show_sort_weight":97,"slug":126},42,"Religión y Espiritualidad","religion-spirituality",{"id":11,"doc_module":4,"doc_module_name":47,"category_name":12,"show_sort_weight":97,"slug":128},"healthcare",{"id":130,"doc_module":4,"doc_module_name":47,"category_name":131,"show_sort_weight":97,"slug":132},24,"Tecnología","technology"]